MYP_152549
Basic Information
P-57
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
23 amino acids
C127H208N34O44
Standard
Sequence
WEQKIEELLKKAEEQQKKNEEEK
Physicochemical Analysis
2915.21 Da
4.94
-2.22
-2.45
-0.0967
-2.28
0.63
-0.58
103.10
55.22
0.0435
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1346.19
-10.69
43.0
42.0
112.0
205.0
2.0
26.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0394200 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells
0.75 μM
IC50
RECORD: Rec_0411973 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 HXB2 | TZM-bl cells
0.75 μM
IC50
Mammalian: 2.8 h; Yeast: 3 min; E. coli: 2 min
Showing 2 records on this page · Page 2 of 2